New York Bird Flu Drill Finds 40% of Health Facilities Missed Basics
A regional drill using actors with H5 bird flu symptoms found only 60 percent of 73 healthcare facilities masked and isolated the patient, with delays in screening, PPE and infection-control notification.

A New York regional outbreak drill found that 40 percent of participating healthcare facilities failed a basic first-response test built around a possible H5 bird flu case, Ars Technica reported from a Morbidity and Mortality Weekly Report study.
The exercise sent trained patient actors into 73 healthcare facilities with staged symptoms and a story about handling a sick duck.
The goal was narrow but important: identify a potentially infectious febrile patient, offer masking and move the patient into isolation before a respiratory virus could spread in a waiting room.
Only 44 of the 73 facilities completed both required actions.
Emergency departments, which made up 42 of the visits, had the weakest result among the three facility types, with about 55 percent masking and isolating the actor.
Hospital outpatient clinics passed 68 percent of the time, while urgent care centers passed 67 percent.
The result matters because the drill did not require a definitive diagnosis, specialized laboratory work or a complex treatment decision.
Passing meant putting a mask on the coughing patient and placing that person in an isolation room.
Even among the facilities that performed both steps, speed lagged behind the preferred targets.
The benchmark called for masking within one minute and isolation within 10 minutes.
Fewer than half of the facilities that passed met the masking target, and fewer than half met the isolation target.
Across all visits, the median time to mask was two minutes, while the median time to isolation was 11 minutes.
Outpatient clinics had a median isolation time of 20 minutes, and at least one clinic took nearly an hour.
The actors visited facilities from January through June 2026.
Most visits took place in New York City, with 52 facilities in the city, 15 elsewhere in New York, three in New Jersey and three in the U.S. Virgin Islands.
The facilities had agreed to participate in drills, but they did not know when the actors would arrive.
Screening was common but incomplete.
Staff at 93 percent of the facilities checked the actor for symptoms, yet only seven facilities asked questions specific to bird flu exposure, despite the actor volunteering a story about trying to save a sick duck in a park.
Eighteen percent of facilities did not offer a mask to a coughing patient who said they had a fever.
Protective equipment use also varied.
Only 25 percent of clinicians interacting with the actors wore all recommended items: gloves, mask, gown and eye protection.
Six percent wore none of the recommended equipment, and 19 percent did not wear a mask or respirator.
Staff at 40 of the 73 facilities, or 55 percent, notified or planned to notify internal infection prevention and control teams.
The study authors framed the gaps as a training problem at the earliest point of contact.
Faster recognition, masking and isolation are basic controls for respiratory infections, and the drill suggests that even prepared facilities can miss or delay those steps when a plausible patient arrives without warning.
The setup also tested whether staff could connect a routine respiratory complaint to a specific exposure history.
The actor did not begin by announcing bird flu risk.
Staff had to ask enough follow-up questions to link fever, conjunctivitis, cough and contact with a dead duck.
That step matters because a waiting-room response can start before laboratory confirmation, and a missed exposure clue can leave other patients and clinicians in the same space longer than necessary.
The findings may still overstate readiness.
Participation was voluntary, so facilities that declined the drill could have performed worse.
Some participants may also have received informal warning that a test was possible.
Against that backdrop, a 60 percent pass rate leaves the region with a measurable first-contact weakness before the next serious respiratory outbreak.




















